Literature DB >> 32651063

Next-Generation Sequencing Identified a Novel Crizotinib-Sensitive PLB1-ALK Rearrangement in Lung Large-Cell Neuroendocrine Carcinoma.

Shuai Wang1, Xuan Wu1, Jiuzhou Zhao2, Haiyang Chen1, Zhe Zhang1, Mingyue Wang1, Cong Xu1, Yongsen Wang2, Lili Wang1, Zhen He1, Qiming Wang3.   

Abstract

Entities:  

Keywords:  Crizotinib; Generation sequencin; Lung large-cell neuroendocrine carcinoma; PLB1-ALK; Sensitivity

Mesh：

Substances：

Year:  2020        PMID： 32651063     DOI： 10.1016/j.cllc.2020.05.026

Source DB:  PubMed          Journal:  Clin Lung Cancer        ISSN： 1525-7304            Impact factor:   4.785


× No keyword cloud information.
  3 in total

Review 1.  Molecular Pathology of Pulmonary Large Cell Neuroendocrine Carcinoma: Novel Concepts and Treatments.

Authors:  Masayo Yoshimura; Kurumi Seki; Andrey Bychkov; Junya Fukuoka
Journal:  Front Oncol       Date:  2021-04-22       Impact factor: 6.244

2.  Identification of Tumor Antigens and Immune Subtypes of Glioblastoma for mRNA Vaccine Development.

Authors:  Han Lin; Kun Wang; Yuxin Xiong; Liting Zhou; Yong Yang; Shanwei Chen; Peihong Xu; Yujun Zhou; Rui Mao; Guangzhao Lv; Peng Wang; Dong Zhou
Journal:  Front Immunol       Date:  2022-02-02       Impact factor: 7.561

3.  Case Report: A Pregnant Woman Diagnosed as ALK-Rearrangement Lung Large Cell Neuroendocrine Cancer With Brain Metastasis.

Authors:  Zaixiang Fu; Ganggui Zhu; Liquan Wang; Shen Hu; Lu Cheng; Fuyi Liu
Journal:  Front Oncol       Date:  2022-02-25       Impact factor: 6.244
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.